Bromhexine HydrochlorideThird Party Manufacturing in India

Bromhexine Hydrochloride works as a mucolytic and secretolytic agent that improves the clearance of mucus from the respiratory tract. It acts by depolymerizing mucopolysaccharide fibers present in the mucus, which reduces the viscosity and adhesiveness of bronchial secretions. Bromhexine stimulates the production of serous bronchial secretions while simultaneously increasing the activity of hydrolytic enzymes in the mucus, leading to fragmentation of acid mucopolysaccharide chains. This dual action transforms thick, tenacious sputum into a thinner, more fluid consistency that is easier to expectorate.

Beyond its direct mucolytic effect, bromhexine enhances mucociliary clearance by stimulating ciliary activity in the respiratory epithelium. The drug also promotes the synthesis and release of pulmonary surfactant by type II alveolar pneumocytes. Surfactant acts as an anti-glue factor that prevents adhesion of mucus to the bronchial walls, further facilitating mucus clearance.

Bromhexine is rapidly absorbed from the gastrointestinal tract and undergoes extensive first-pass metabolism in the liver, where it is converted to its active metabolite ambroxol. Both bromhexine and its metabolite contribute to the overall mucolytic effect. Clinical studies have demonstrated that bromhexine reduces sputum viscosity, increases sputum volume initially, and subsequently reduces overall sputum production as the underlying condition resolves.

Therapeutic Uses

Bromhexine Hydrochloride is prescribed for the treatment of:

• Acute and Chronic Bronchitis: Reduces sputum viscosity and facilitates expectoration in patients with productive cough associated with bronchial inflammation.
• Chronic Obstructive Pulmonary Disease (COPD): Used as an adjunct in the management of COPD to improve mucus clearance and reduce cough severity during acute exacerbations.
• Bronchiectasis: Helps patients with bronchiectasis clear accumulated secretions from the dilated airways, reducing the risk of recurrent infections.
• Sinusitis: Promotes drainage of thickened mucus from the paranasal sinuses, relieving sinus pressure and congestion.
• Asthma with Mucus Hypersecretion: Used as an adjunct in asthmatic patients who have difficulty clearing thick bronchial secretions.
• Post-operative Respiratory Care: Administered to prevent mucus plugging and maintain airway patency following thoracic or abdominal surgery.

Why Manufacturers Choose Bromhexine Hydrochloride

Bromhexine is one of the most widely prescribed mucolytic agents globally, with consistent demand across all age groups. It is included in the WHO Essential Medicines List and is available as a low-cost generic, making it accessible in both developed and developing healthcare markets. The syrup formulation is particularly suitable for pediatric and geriatric patients who have difficulty swallowing tablets. Indian manufacturers benefit from well-established production processes, abundant API availability from domestic sources, and strong export demand to regulated markets across Asia, Africa, and the Middle East. Bromhexine syrup is a staple product for any respiratory portfolio and remains one of the highest-volume liquid oral products in Indian pharmaceutical manufacturing.

This makes Bromhexine Hydrochloride a staple molecule for third party manufacturing in India, with steady demand across PCD franchise networks and export channels.